login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
VIRAX BIOLABS GROUP LTD (VRAX) Stock News
USA
- NASDAQ:VRAX -
KYG9495L1251
-
Common Stock
0.62
USD
-0.01 (-1.6%)
Last: 9/17/2025, 11:45:28 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VRAX Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Benzinga
- Mentions:
BRKR
CLDX
KPTI
MBOT
...
12 Health Care Stocks Moving In Monday's After-Market Session
21 days ago - By: Yahoo Finance
Virax Biolabs (VRAX) Falls 18% on Lack of Leads
22 days ago - By: Benzinga
- Mentions:
EPIX
WORX
THAR
NLSP
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
22 days ago - By: Virax Biolabs Group Limited
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
2 months ago - By: Virax Biolabs Group Limited
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy
2 months ago - By: Virax Biolabs Group Limited
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
6 months ago - By: Virax Biolabs
Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
6 months ago - By: Virax Biolabs
Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
7 months ago - By: Virax Biolabs
Virax Biolabs to Present at 19th World Immune Regulation Meeting
9 months ago - By: Virax Biolabs
Virax Biolabs' CEO James Foster Issues Letter to Shareholders
9 months ago - By: Virax Biolabs
Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
a year ago - By: Virax Biolabs
Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
a year ago - By: Virax Biolabs
- Mentions:
COSM
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
a year ago - By: Virax Biolabs
Virax Biolabs to Participate at 7th European Congress of Immunology
a year ago - By: Virax Biolabs
Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East
a year ago - By: Virax Biolabs
Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
a year ago - By: Virax Biolabs
Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares
Please enable JavaScript to continue using this application.